Fever and acute urticaria in a young male patient


Submitted: 15 July 2022
Accepted: 28 July 2022
Published: 27 September 2022
Abstract Views: 1659
PDF: 229
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

A 23-year-old man presented to our emergency department with a new onset of low-grade fever associated with diffuse itching urticarial rash localized to his trunk and upper limbs. He denied respiratory and gastrointestinal symptoms. Peripheral oxygen saturation was 98% at room ambient. His past medical history was unremarkable, and he was not taking any medications. No history of allergies was reported. He denied traveling abroad, contact with animals, ingesting raw meat or fish, or taking medicine. Laboratory results showed leukopenia with lymphocytopenia and normal C-reactive protein value. Eosinophils were normal. Hepatic and renal tests were all within the normal range. He was vaccinated with 3 doses of Comirnaty vaccine with no adverse reactions. Lung ultrasound showed A pattern without pleural effusion. The patient was discharged with oral steroids (prednisone 25 mg for three days with a progressive reduction in 10 days) and oral antihistamine (bilastine 10 mg daily for 10 days), and acetaminophen 1 gr if fever above 37.5°C, with complete resolution of the rash without sequelae in 10 days.


Molina-Ruiz AM, Santonja C, Rütten A, et al. Immunohistochemistry in the diagnosis of cutaneous viral infections--part I. Cutaneous viral infections by herpesviruses and papillomaviruses. Am J Dermatopathol 2015;37:1-14; quiz 12-4. DOI: https://doi.org/10.1097/DAD.0000000000000203

Galvan Casas C, Catala A, Carretero Hernandez G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020;183:71-7. DOI: https://doi.org/10.1111/bjd.19347

Pagali S, Parikh RS. Severe urticarial rash as the initial symptom of COVID-19 infection. BMJ Case Reports CP 2021;14:e241793. DOI: https://doi.org/10.1136/bcr-2021-241793

Algaadi SA. Urticaria and COVID-19: A review. Dermatol Ther 2020;33:e14290. DOI: https://doi.org/10.1111/dth.14290

Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020;34:e212–3. DOI: https://doi.org/10.1111/jdv.16387

Bastoni D, Borio G, Rienzo P, et al. COVID-19 and cutaneous manifestations: two cases and a review of the literature. Emergency Care Journal 2022,18:10468. DOI: https://doi.org/10.4081/ecj.2022.10468

Rodríguez-Jiménez P, Chicharro P, De Argila D, et al. Urticaria-like lesions in COVID-19 patients are not really urticaria - a case with clinicopathological correlation. J Eur Acad Dermatol Venereol 2020;34:e459-60. DOI: https://doi.org/10.1111/jdv.16618

Borio, G., & Farolfi, F. (2022). Fever and acute urticaria in a young male patient. Emergency Care Journal, 18(3). https://doi.org/10.4081/ecj.2022.10742

Downloads

Download data is not yet available.

Citations


Similar Articles

You may also start an advanced similarity search for this article.